Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

BACKGROUND: Although a recent study reported that fibrates are associated with a low risk of cardiovascular (CV) death and can postpone the need for long-term hemodialysis in patients with advanced chronic kidney disease (CKD), little is known regarding whether the CV protective effects of fibrates...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Wen-Yu, Yen, Chieh-Li, Lee, Cheng-Chia, Tu, Yi-Ran, Chen, Chao-Yu, Hsiao, Ching-Chung, Chu, Pao-Hsien, Hsu, Hsiang-Hao, Tian, Ya-Chun, Chang, Chih-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681823/
https://www.ncbi.nlm.nih.gov/pubmed/36440016
http://dx.doi.org/10.3389/fcvm.2022.907539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681823/
https://www.ncbi.nlm.nih.gov/pubmed/36440016
http://dx.doi.org/10.3389/fcvm.2022.907539

Ejemplares similares